A Tumor-Selective Monoclonal Antibody from Immunization with a Tumor-Associated Mucin Glycopeptide
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A Tumor-Selective Monoclonal Antibody from Immunization with a Tumor-Associated Mucin Glycopeptide ; volume:9 ; number:1 ; day:5 ; month:4 ; year:2019 ; pages:1-12 ; date:12.2019
Scientific reports ; 9, Heft 1 (5.4.2019), 1-12, 12.2019
- Klassifikation
-
Naturwissenschaften
- Urheber
-
Trabbic, Kevin R.
Whalen, Kaitlyn
Abarca-Heideman, Karin
Xia, Li
Temme, J. Sebastian
Edmondson, Elijah F.
Gildersleeve, Jeffrey C.
Barchi, Joseph J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-42076-2
- URN
-
urn:nbn:de:101:1-2019042121093006355270
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Trabbic, Kevin R.
- Whalen, Kaitlyn
- Abarca-Heideman, Karin
- Xia, Li
- Temme, J. Sebastian
- Edmondson, Elijah F.
- Gildersleeve, Jeffrey C.
- Barchi, Joseph J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Tumor-associated collagen signatures: pushing tumor boundaries
NDRG2 programs tumor-associated macrophages for tumor support
Tumor-associated macrophages in meningioma
The Development of Vaccines from Synthetic Tumor‐Associated Mucin Glycopeptides and their Glycosylation‐Dependent Immune Response
The development of vaccines from synthetic tumor-associated mucin glycopeptides and their glycosylation-dependent immune response
Tumor-associated macrophages: an accomplice in solid tumor progression
Progress in reeducating tumor-associated macrophages in tumor microenvironment
Tumor-associated neutrophils during Pseudomonas aeruginosa-mediated tumor therapy
MicroRNA - a tumor trojan horse for tumor-associated macrophages
The role of tumor-associated macrophages in tumor immune evasion
Tumor-associated myeloid cells in cancer immunotherapy
Tumor-associated lymphangiogenesis in conjunctival malignant melanoma
Tumor-associated collagen signatures: pushing tumor boundaries
NDRG2 programs tumor-associated macrophages for tumor support
Tumor-associated macrophages in meningioma
The Development of Vaccines from Synthetic Tumor‐Associated Mucin Glycopeptides and their Glycosylation‐Dependent Immune Response
The development of vaccines from synthetic tumor-associated mucin glycopeptides and their glycosylation-dependent immune response
Tumor-associated macrophages: an accomplice in solid tumor progression
Progress in reeducating tumor-associated macrophages in tumor microenvironment
Tumor-associated neutrophils during Pseudomonas aeruginosa-mediated tumor therapy
MicroRNA - a tumor trojan horse for tumor-associated macrophages
The role of tumor-associated macrophages in tumor immune evasion
Tumor-associated myeloid cells in cancer immunotherapy
Tumor-associated lymphangiogenesis in conjunctival malignant melanoma
Tumor-associated collagen signatures: pushing tumor boundaries
NDRG2 programs tumor-associated macrophages for tumor support
Tumor-associated macrophages in meningioma
The Development of Vaccines from Synthetic Tumor‐Associated Mucin Glycopeptides and their Glycosylation‐Dependent Immune Response
The development of vaccines from synthetic tumor-associated mucin glycopeptides and their glycosylation-dependent immune response
Tumor-associated macrophages: an accomplice in solid tumor progression
Progress in reeducating tumor-associated macrophages in tumor microenvironment
Tumor-associated neutrophils during Pseudomonas aeruginosa-mediated tumor therapy
MicroRNA - a tumor trojan horse for tumor-associated macrophages
The role of tumor-associated macrophages in tumor immune evasion
Tumor-associated myeloid cells in cancer immunotherapy